MRI-guided radiation therapy (MRgRT) is an emerging, innovative technology that provides opportunities to transform and improve the current clinical care process in radiation oncology. As with many new technologies in radiation oncology, careful evaluation from a healthcare economic and policy perspective is required for its successful implementation. In this review article, we describe the current evidence surrounding MRgRT, framing it within the context of value within the healthcare system. Additionally, we highlight areas in which MRgRT may disrupt the current process of care, and discuss the evidence thresholds and timeline required for the widespread adoption of this promising technology.

MRI 引导放射治疗 (MRgRT) 是一项新兴的创新技术，为转变和改进当前放射肿瘤学临床护理流程提供了机会。与放射肿瘤学中的许多新技术一样，其成功实施需要从医疗保健经济和政策角度进行仔细评估。在这篇综述文章中，我们描述了围绕 MRgRT 的当前证据，并将其置于医疗保健系统的价值背景下。此外，我们还重点介绍了 MRgRT 可能会扰乱当前护理流程的领域，并讨论了广泛采用这一有前途的技术所需的证据阈值和时间表。